Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2
Elena Mitsi, Jesús Reiné, Britta C. Urban, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 7
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 66
Effect of pneumococcal conjugate vaccines and SARS-CoV-2 on antimicrobial resistance and the emergence of Streptococcus pneumoniae serotypes with reduced susceptibility in Spain, 2004–20: a national surveillance study
Julio Sempere, Mirella Llamosí, Beatriz López Ruiz, et al.
The Lancet Microbe (2022) Vol. 3, Iss. 10, pp. e744-e752
Open Access | Times Cited: 39
Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination
Elena Mitsi, Mariana O. Diniz, Jesús Reiné, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 29
A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United Kingdom
James Campling, Andrew Vyse, Hui-Hsuan Liu, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 785-800
Open Access | Times Cited: 15
Serotype, antibiotic susceptibility and whole-genome characterization of Streptococcus pneumoniae in all age groups living in Southwest China during 2018–2022
Chenglin Miao, Ziyi Yan, Chunmei Chen, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 5
Serotype Distribution and Disease Severity in Adults Hospitalized with Streptococcus pneumoniae Infection, Bristol and Bath, UK, 2006‒2022
Catherine Hyams, Robert Challen, David Hettle, et al.
Emerging infectious diseases (2023) Vol. 29, Iss. 10
Open Access | Times Cited: 14
Peptide linker increased the stability of pneumococcal fusion protein vaccine candidate
Luciano Zane, Stefanie Kraschowetz, Monalisa Martins Trentini, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 13
Streptococcus pneumoniae epidemiology, pathogenesis and control
Ana Rita Narciso, Rebecca S. Dookie, Priyanka Nannapaneni, et al.
Nature Reviews Microbiology (2024)
Closed Access | Times Cited: 4
Correlation of Influenza Vaccination and the COVID-19 Severity
Mark Christopher Arokiaraj
SSRN Electronic Journal (2020)
Closed Access | Times Cited: 34
Association of Upper Respiratory Streptococcus pneumoniae Colonization With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Adults
Anna M Parker, Nicole Jackson, Shevya Awasthi, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 7, pp. 1209-1217
Open Access | Times Cited: 19
Effectiveness of Pneumococcal Conjugate Vaccination Against Virus-Associated Lower Respiratory Tract Infection Among Adults: A Case-Control Study
Joseph A. Lewnard, Katia Bruxvoort, Vennis Hong, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 4, pp. 498-511
Open Access | Times Cited: 18
Effects of pneumococcal conjugate vaccines on reducing the risk of respiratory disease associated with coronavirus infection
Eileen M. Dunne, Marta C. Nunes, Mary Slack, et al.
Pneumonia (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 9
The regulation of HBP1, SIRT1, and SREBP-1c genes and the related microRNAs in non-alcoholic fatty liver rats: The association with the folic acid anti-steatosis
Muthana S.K. Salman, Maher A. Kamel, Sobhy Hassab El‐Nabi, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0265455-e0265455
Open Access | Times Cited: 15
Profile of the Nasopharyngeal Microbiota Affecting the Clinical Course in COVID-19 Patients
Ornella La Fortune Tchoupou Saha, G Dubourg, Abdourahamane Yacouba, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 15
Effect of Pneumococcal Conjugate Vaccines on Viral Respiratory Infections: A Systematic Literature Review
Ingrid T. Sepúlveda-Pachón, Eileen M. Dunne, Germaine Hanquet, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 3, pp. e657-e667
Open Access | Times Cited: 2
Human Infection Challenge with Serotype 3 Pneumococcus
Ryan Robinson, Elena Mitsi, Elissavet Nikolaou, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 206, Iss. 11, pp. 1379-1392
Open Access | Times Cited: 12
Community-acquired bacterial coinfections and COVID-19
Michael J. Patton, Amit Gaggar, Matthew Might, et al.
Physiological Reviews (2023) Vol. 104, Iss. 1, pp. 1-21
Closed Access | Times Cited: 7
Coinfection of SARS-CoV-2 with other respiratory pathogens in outpatients from Ecuador
Diana Morales-Jadán, Claire Muslin, Carolina Viteri-Dávila, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 7
Antimicrobial effect of quercetin against Streptococcus pneumoniae
Eduardo Willian de Alencar Pereira, Valéria Costa Fontes, Érika Alves da Fonsêca Amorim, et al.
Microbial Pathogenesis (2023) Vol. 180, pp. 106119-106119
Closed Access | Times Cited: 5
Impact of respiratory viral infections on nasopharyngeal pneumococcal colonization dynamics in children
Leigh M. Howard, Carlos G. Grijalva
Current Opinion in Infectious Diseases (2024) Vol. 37, Iss. 3, pp. 170-175
Closed Access | Times Cited: 1
Adult risk groups for vaccine preventable respiratory infections: an overview of the UK environment
Charles Reynard, James Campling, Adam Gordon, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 1052-1067
Open Access | Times Cited: 1
Development of lab score system for predicting COVID-19 patient severity: A retrospective analysis
Arnab Sarkar, S.C. Sanyal, A. S. Majumdar, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0273006-e0273006
Open Access | Times Cited: 6
Burden of Lower Respiratory Tract Infections Preventable by Adult Immunization With 15- and 20-Valent Pneumococcal Conjugate Vaccines in the United States
Joseph A. Lewnard, Vennis Hong, Katia Bruxvoort, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. 9, pp. 1340-1352
Open Access | Times Cited: 3
Public health and budgetary impact of 20-valent pneumococcal conjugate vaccine for adults in England
Tendai Mugwagwa, Ahuva Averin, Mark Atwood, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 9, pp. 1331-1341
Open Access | Times Cited: 5
Longitudinal dynamics ofStreptococcus pneumoniaecarriage and SARS-CoV-2 infection in households with children
Willem R. Miellet, Rob Mariman, Dirk Eggink, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top